secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMMUNIC, INC. (IMUX)
CIK:        0001280776
Form:       8-K
Filed at:   2026-04-23T23:59:59+00:00
Accession:  0001193805-26-000495
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immunic announces 1-for-10 reverse stock split effective April 27, 2026
-----------------------------------------------------------------------

- Reverse stock split at 1-for-10 ratio; reduces outstanding shares from ~136M to ~13.6M.
- Effective 12:01 a.m. ET on April 27, 2026; trading on Nasdaq (IMUX) begins split-adjusted same day.
- New CUSIP: 4525EP200; no fractional shares issued, cash in lieu for fractional amounts.
- Board determined ratio after stockholder approval on April 14, 2026.
- Split intended to meet contractual obligations under Feb 12, 2026 securities purchase agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1280776/000119380526000495/0001193805-26-000495-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1280776/000119380526000495/e665386_8k-immunic.htm
  HTML page:      https://secwatch.observer/filing/0001193805-26-000495

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer